Join this upcoming webinar to learn how to simplify your nucleic acid extraction, limit operator-dependent variation and improve the traceability of your workflows
Thermo Fisher Scientific will provide 50 Ion Torrent Genexus Systems for consortia members to support global COVID-19 research
The randomized, double-blind, placebo-controlled study aims to enroll up to 40 patients with moderate-to-severe COVID-19 pneumonia in the U.S
New Ion AmpliSeq SARS-CoV-2 Research Panel assists with contact tracing to identify coronavirus hot spots
INHECO presents new options for liquid-handling workflows
The real-time PCR system aims to accelerate coronavirus research and diagnostics
Join SelectScience on Tuesday, May 12, at the Virtual Summit on Cancer and Immunology Research to find out the winner
Join this expert webinar for a review of the power of microfluidics for dynamic time-lapse experiments
Watch this on-demand SelectScience webinar to learn about STARLIMS and how it can be used to support the entire life cycle of your samples
Clinical laboratories certified to perform high complexity tests under Clinical Laboratory Improvement Amendments (CLIA) can immediately begin using this ELISA
Register today to reserve a place at the Summit - it opens at 13:00 (BST) / 14:00 (CEST) / 08:00 (EDT) / 05:00 (PDT) on Monday, May 11
AMSBIO's new service utilizes their novel lentiviral system to aid the development of therapeutic drugs and vaccines
The U.S. Food and Drug Administration has approved Tabrecta (capmatinib) to treat adult patients with non-small cell lung cancer
Up to five different fluorescence channels are designed to allow researchers to explore new applications, such as metabolism, with addition of new live-cell ATP and MMP assays
Preliminary results from a government-sponsored study suggest that drug used to treat Ebola may help COVID-19 patients
Innovosens building partnerships to accelerate development, testing and market launch
The blood-based immunoassay test enables clinicians to identify the virus linked with COVID-19
Introducing Univercells Technologies, Univercells’ subsidiary focused on the development and commercialization of intensified, automated biomanufacturing technologies
Automated workflow optimized to extract pure DNA/RNA from the novel coronavirus, SARS-CoV-2
Bio-Rad Laboratories has launched a range of anti-certolizumab pegol inhibitory antibodies to support the development of anti-drug antibody (ADA) assays
Designed with a porous glass membrane for transmigration and transport studies under both static and flow conditions
